Global Bioabsorbable Stents Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Bioabsorbable Stents Market size is expected to reach USD 860.35 Million in 2034 from USD 473.12 Million (2025) growing at a CAGR of 6.87% during 2026-2034.

The global bioabsorbable stents market has grown as healthcare providers explore advanced solutions for treating cardiovascular diseases. Bioabsorbable stents are medical devices used to open blocked arteries and gradually dissolve in the body over time. Unlike traditional metal stents, these devices provide temporary support and reduce long-term complications associated with permanent implants.

Several factors are driving the growth of the bioabsorbable stents market. Increasing prevalence of cardiovascular diseases and growing demand for minimally invasive treatment options have encouraged the development of innovative stent technologies. Bioabsorbable stents offer the advantage of restoring natural vessel function after the device dissolves, making them attractive in certain clinical applications.

Looking ahead, the bioabsorbable stents market is expected to expand as research in cardiovascular devices continues to advance. Improvements in material science and stent design may enhance safety and effectiveness. As healthcare providers seek advanced solutions for heart disease treatment, bioabsorbable stents may play an important role in future cardiovascular care.

MARKET SEGMENTATION

By Biomaterial

Bioabsorbable Polymer-based Stents
Bioabsorbable Metallic Stents

By Application

Coronary Artery Disease
Peripheral Artery Disease

By Absorption Rate

Slow Absorption Rate
Fast Absorption Rate

By End User

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

COMPANIES PROFILED

Amaranth Medical, Arterial Remodeling Technologies, Arterius Limited, B Braun Melsungen AG, Biotronik SE Co KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co Ltd, MicroPort Scientific Corporation, Reva Medical, Terumo Corporation
We can customise the report as per your requirements.

Product Code: VMR11213618

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOABSORBABLE STENTS MARKET: BY BIOMATERIAL 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Biomaterial
4.2. Bioabsorbable Polymer-based Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Bioabsorbable Metallic Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOABSORBABLE STENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Application
5.2. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOABSORBABLE STENTS MARKET: BY ABSORPTION RATE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Absorption Rate
6.2. Slow Absorption Rate Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Fast Absorption Rate Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOABSORBABLE STENTS MARKET: BY END USER 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End User
7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOABSORBABLE STENTS MARKET: BY REGION 2022-2034 (USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Biomaterial
- 8.2.2 By Application
- 8.2.3 By Absorption Rate
- 8.2.4 By End User
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Biomaterial
- 8.3.2 By Application
- 8.3.3 By Absorption Rate
- 8.3.4 By End User
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Biomaterial
- 8.4.2 By Application
- 8.4.3 By Absorption Rate
- 8.4.4 By End User
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Biomaterial
- 8.5.2 By Application
- 8.5.3 By Absorption Rate
- 8.5.4 By End User
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Biomaterial
- 8.6.2 By Application
- 8.6.3 By Absorption Rate
- 8.6.4 By End User
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOABSORBABLE STENTS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Amaranth Medical
- 10.2.2 Arterial Remodeling Technologies
- 10.2.3 Arterius Limited
- 10.2.4 B. Braun Melsungen AG
- 10.2.5 Biotronik SE & Co. KG
- 10.2.6 Boston Scientific Corporation
- 10.2.7 Elixir Medical Corporation
- 10.2.8 Kyoto Medical Planning Co. Ltd
- 10.2.9 MicroPort Scientific Corporation
- 10.2.10 Reva Medical
- 10.2.11 Terumo Corporation